"the reality is the entire company is now worth significantly less..."
KSD, you just indicated either a lack of knowledge of basic valuation, or are being deliberately misleading (you choose).
Your statement refers to the firm's market capitalization. Although important, market cap isn't the firm's "worth". Instead, a company's "worth" is usually considered its break-apart value, typically its net tangible asset value (book value).
DNA's book value was 57 cents per share in June 2016, and is estimated to be worth 61 cents in 2017. In short, the market (as usual) is swinging its pendulum far from the firm's worth.
- Forums
- ASX - By Stock
- DNA
- Time to buy DNA!
Time to buy DNA!, page-101
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DNA (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.76M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 93361 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 202586 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 93361 | 0.030 |
2 | 170515 | 0.029 |
3 | 214320 | 0.028 |
2 | 137072 | 0.027 |
1 | 134000 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 29440 | 1 |
0.034 | 300000 | 1 |
0.035 | 83823 | 2 |
0.036 | 14000 | 1 |
0.037 | 236668 | 2 |
Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
DNA (ASX) Chart |
Day chart unavailable